ADVFN Logo ADVFN

No pudimos encontrar ningún resultado para:
Asegúrate de que la ortografía sea correcta o intenta ampliar tu búsqueda.

Tendencias Ahora

Listas Principales

Parece que no has iniciado sesión.
Haz clic en el botón de abajo para iniciar sesión y ver tu historial reciente.

Regístrate

¿Ya eres miembro? Iniciar sesión

Los Principales Corredores en Línea

Más Corredores en Línea

Datos
Noticias
Herramientas
Mercados
Descubrir

Hot Features

Follow Feed

Conéctese con traders e inversores en nuestra comunidad Follow Feed.

Flujo de Opciones

Explora datos de opciones completos y utiliza filtros avanzados con Options Flow.

Monitor

Organiza y monitorea tu lista de seguimiento de acciones y activos con Monitor.
Iniciar Sesión Premium IconPremium Help Menu
S&P 500
5,277.51
0.80%
Dow Jones
38,686.32
1.51%
US Dollar vs MXN
16.99024
0.00%
Brent Oil
81.295
0.00%
Bitcoin
67,504.81
-0.33%
Registration Strip Icon for monitor Monitoree múltiples cotizaciones en tiempo real de los principales intercambios, como la Bolsa de Valores de Londres, NASDAQ, NYSE, AMEX, Bovespa y más.
Regístrate
  1. Inicio
  2. Invertir
  3. Acciones
  4. Estados Unidos
  5. NASDAQ
  6. Galapagos NV (GLPG)

  7. Galapagos NV (GLPG) Noticias

GLPG

Galapagos NV (GLPG)

Galapagos NV
Fecha:
Ordernar por:
 Showing the most relevant articles for your search:NASDAQ:GLPG
FechaHoraFuenteTítuloSímboloCompañía
30/05/202415:44Edgar (US Regulatory)Form 6-K - Report of foreign issuer [Rules 13a-16 and 15d-16]NASDAQ:GLPGGalapagos NV
30/05/202415:01GlobeNewswire Inc.Galapagos and Adaptimmune sign clinical collaboration agreement with an option to exclusively license Adaptimmune’s TCR T-cell therapy candidate, uza-cel, in head & neck cancer and potential future solid tumor indicationsNASDAQ:GLPGGalapagos NV
16/05/202415:01GlobeNewswire Inc.Galapagos creates new subscription right plansNASDAQ:GLPGGalapagos NV
15/05/202415:01GlobeNewswire Inc.Galapagos and Blood Centers of America announce strategic collaboration to accelerate Galapagos’ decentralized CAR-T manufacturing network in the U.S.NASDAQ:GLPGGalapagos NV
02/05/202415:01GlobeNewswire Inc.Galapagos reports first quarter 2024 financial results  NASDAQ:GLPGGalapagos NV
30/04/202415:01GlobeNewswire Inc.Galapagos’ shareholders adopt all resolutions proposed by the Board of Directors at the Annual and Extraordinary Shareholders Meetings 2024NASDAQ:GLPGGalapagos NV
04/04/202415:01GlobeNewswire Inc.Galapagos showcases innovative approach in hematological cancer care with clinical and translational data presentations at EBMT congress 2024NASDAQ:GLPGGalapagos NV
28/03/202415:01GlobeNewswire Inc.Galapagos publishes 2023 annual report and announces Annual and Extraordinary Shareholders’ MeetingsNASDAQ:GLPGGalapagos NV
26/03/202415:01GlobeNewswire Inc.Galapagos appoints Andrew Dickinson as Non-Executive Non-Independent Director to its BoardNASDAQ:GLPGGalapagos NV
22/02/202415:01GlobeNewswire Inc.Frontier Medicines Announces Oversubscribed $80 Million Series C Financing to Support Progress of Clinical-Stage PipelineNASDAQ:GLPGGalapagos NV
22/02/202415:01GlobeNewswire Inc.Galapagos announces full year 2023 results and outlook for 2024NASDAQ:GLPGGalapagos NV
15/02/202415:01GlobeNewswire Inc.Galapagos presents at EBMT-EHA annual meeting 2024NASDAQ:GLPGGalapagos NV
14/02/202416:41Edgar (US Regulatory)Form SC 13G/A - Statement of acquisition of beneficial ownership by individuals: [Amend]NASDAQ:GLPGGalapagos NV
31/01/202415:01GlobeNewswire Inc.Galapagos completes transaction to transfer Jyseleca® business to AlfasigmaNASDAQ:GLPGGalapagos NV
04/01/202415:44Dow Jones NewsGalapagos, Thermo Fisher to Collaborate on Expanding Manufacturing of Cancer DrugNASDAQ:GLPGGalapagos NV
04/01/202415:01GlobeNewswire Inc.Galapagos enters into strategic collaboration agreement with Thermo Fisher Scientific to further expand its decentralized CAR-T manufacturing network in the U.S.NASDAQ:GLPGGalapagos NV
03/01/202415:01GlobeNewswire Inc.Galapagos establishes strategic collaboration with BridGene Biosciences to expand small molecule drug discovery in oncologyNASDAQ:GLPGGalapagos NV
03/01/202415:01PR Newswire (US)BridGene Biosciences Announces Strategic Collaboration with Galapagos to Discover Small Molecule Drugs for Oncology TargetsNASDAQ:GLPGGalapagos NV
02/01/202400:00GlobeNewswire Inc.Galapagos signs agreement to transfer Jyseleca® business to AlfasigmaNASDAQ:GLPGGalapagos NV
19/12/202315:01GlobeNewswire Inc.Galapagos announces start of PAPILIO-1 Phase 1/2 multiple myeloma study of point-of-care manufactured BCMA CAR-T candidate, GLPG5301NASDAQ:GLPGGalapagos NV
09/12/202311:00GlobeNewswire Inc.Galapagos presents new encouraging data at ASH 2023 from ongoing CD19 CAR-T studies with GLPG5201 and GLPG5101NASDAQ:GLPGGalapagos NV
07/12/202315:01GlobeNewswire Inc.Galapagos to Host KOL Event on December 10, 2023, at 11:00 AM PST to discuss new data presented at ASH 2023NASDAQ:GLPGGalapagos NV
06/11/202306:45PR Newswire (US)Landmark Bio Signs Multi-Year Agreement to Manufacture Galapagos' Oncology CAR-T Cell Therapy Clinical Programs at the Point-of-CareNASDAQ:GLPGGalapagos NV
02/11/202315:01GlobeNewswire Inc.Galapagos reports third quarter 2023 results and releases new encouraging data from CAR-T studies for presentation at ASH 2023NASDAQ:GLPGGalapagos NV
30/10/202315:01GlobeNewswire Inc.Galapagos concludes strategic evaluation and signs letter of intent to transfer Jyseleca® business to AlfasigmaNASDAQ:GLPGGalapagos NV
19/09/202315:01GlobeNewswire Inc.Galapagos appoints Simon Sturge to its Board of DirectorsNASDAQ:GLPGGalapagos NV
28/08/202315:01GlobeNewswire Inc.Galapagos announces start of Phase 2 study with selective TYK2 inhibitor, GLPG3667, in patients with active systemic lupus erythematosus  NASDAQ:GLPGGalapagos NV
03/08/202315:01GlobeNewswire Inc.Galapagos announces first half-year 2023 financial resultsNASDAQ:GLPGGalapagos NV
15/06/202316:03Edgar (US Regulatory)Report of Foreign Issuer Pursuant to Rule 13a-16 or 15d-16 (6-k)NASDAQ:GLPGGalapagos NV
15/06/202315:01GlobeNewswire Inc.Galapagos appoints Thad Huston as Chief Financial Officer and Chief Operating OfficerNASDAQ:GLPGGalapagos NV
 Showing the most relevant articles for your search:NASDAQ:GLPG

Su Consulta Reciente

COIN
NPASUST
New Paradigm Assets Solution
TSXV
SLHG.H
Skylight Health
LSE
RT93
Compass Grp.30
LSE
38FD
Roy.bk.can.28
Delayed Upgrade Clock
ADVFN Logo
InvestorsHub

México
Empresa
Negocios
Popular
Obtener la aplicación
App Store
Google Play

Soporte: (55) 4170 8128 | soporte@advfn.mx

Al acceder a los servicios disponibles de ADVFN usted acepta quedar sujerto a los Términos y Condiciones

© 2024 ADVFN PLC - Todos los derechos reservados